DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Reau N, Robertson MN, Feng HP. , et al.
Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: a pooled analysis of 1,322 patients with hepatitis C infection.
Hepatol Commun 2017;
1 (08) 757-764
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.